These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 552251)

  • 1. [Actinomycin D: toxic effects with special reference to hepatic injury].
    Mihevc-Srakar N; Petrić-Grabnar G
    Bilt Hematol Transfuz; 1979; 7(1):85-90. PubMed ID: 552251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity and actinomycin D.
    Lancet; 1990 May; 335(8700):1290. PubMed ID: 1971368
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity of actinomycin-D.
    Pritchard J; Raine J; Wallendszus K
    Lancet; 1989 Jan; 1(8630):168. PubMed ID: 2563091
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity with actinomycin D.
    D'Angio GJ
    Lancet; 1987 Jul; 2(8550):104. PubMed ID: 2885556
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the actinomycin-induced nucleolar change by thioacetamide in mouse hepatic parenchymal cell.
    Kume F; Chiga M
    Lab Invest; 1967 Dec; 17(6):767-71. PubMed ID: 4169380
    [No Abstract]   [Full Text] [Related]  

  • 6. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.
    Sulis ML; Bessmertny O; Granowetter L; Weiner M; Kelly KM
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):843-6. PubMed ID: 15591910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinomycin D in childhood acute lymphocytic leukemia.
    Green DM; Sallan SE; Krishan A
    Cancer Treat Rep; 1978 May; 62(5):829-31. PubMed ID: 274997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease in Wilms' tumor.
    Kullendorff CM; Békássy AN
    Eur J Pediatr Surg; 1996 Dec; 6(6):338-40. PubMed ID: 9007466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis following actinomycin D and irradiation.
    Harris F; Cullity G; Lister J
    Proc R Soc Med; 1974 Aug; 67(8):756-7. PubMed ID: 4371666
    [No Abstract]   [Full Text] [Related]  

  • 10. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folliculitis induced by actinomycin D.
    Epstein EH; Lutzner MA
    N Engl J Med; 1969 Nov; 281(20):1094-6. PubMed ID: 5824175
    [No Abstract]   [Full Text] [Related]  

  • 12. Accidental actinomycin D overdosage in man, a case report.
    Choonara IA; Kendall-Smith S; Bailey CC
    Cancer Chemother Pharmacol; 1988; 21(2):173-4. PubMed ID: 3349565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycloheximide protection against actinomycin D cytotoxicity.
    Borrelli MJ; Stafford DM; Rausch CM; Ofenstein JP; Cosenza SC; Soprano KJ
    J Cell Physiol; 1992 Dec; 153(3):507-17. PubMed ID: 1280278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological study of actinomycin D (dactinomycin)].
    Berezina EK; Zhukov VG; Shtegel'man LA
    Antibiotiki; 1970 Dec; 15(12):1081-5. PubMed ID: 5501370
    [No Abstract]   [Full Text] [Related]  

  • 15. Population pharmacokinetic investigation of actinomycin-D in children and young adults.
    Mondick JT; Gibiansky L; Gastonguay MR; Skolnik JM; Cole M; Veal GJ; Boddy AV; Adamson PC; Barrett JS
    J Clin Pharmacol; 2008 Jan; 48(1):35-42. PubMed ID: 18094218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumour: adjuvant treatment with actinomycin D and vincristine.
    Jenkin RD; Jeffs RD; Stephens CA; Sonley MJ
    Can Med Assoc J; 1976 Jul; 115(2):136-40. PubMed ID: 179690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of actinomycin D on mouse thymus in vivo chromatin degradation to nucleosomes and inhibition of RNA and protein synthesis.
    Ermolaeva NV; Matyásová J; Skalka M
    Folia Biol (Praha); 1986; 32(1):36-46. PubMed ID: 2422064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic scintiscanning in fulminant hepatic failure.
    Murray-Lyon IM; Davidson AR; Rake MO; Osborn SB; Williams R
    Br J Radiol; 1973 Jan; 46(541):30-3. PubMed ID: 4683327
    [No Abstract]   [Full Text] [Related]  

  • 19. [Discriminating evaluation of hepatic damage caused by isoniazid and anicteric viral hepatitis, using enzymatic studies and hepatic biopsy].
    Braito A; Bassetti D
    Pathologica; 1969; 61(897):175-84. PubMed ID: 5314702
    [No Abstract]   [Full Text] [Related]  

  • 20. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.